Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 12/27/2025

Management of JJ‑Stent–Associated Urinary Tract Infection and Reactive Lymphadenopathy

Epidemiology & Risk Factors

  • Polymicrobial colonisation of a JJ stent markedly raises the risk of symptomatic urinary infection; reported infection rates for colonised stents range from 11 % to 19 %. [Ca‑A Cancer Journal for Clinicians 2023] 2
  • The likelihood of infection rises proportionally with the duration the stent remains in situ; longer indwelling times are the principal modifiable risk factor. [Ca‑A Cancer Journal for Clinicians 2023] 2

Diagnostic Imaging

  • On FDG‑PET/CT, the sensitivity for detecting lymph‑node metastases in urothelial carcinoma is 82 % and the specificity 84 %; however, FDG uptake is not specific and can be positive in inflammatory or infectious conditions. [Journal of the American College of Radiology 2024] 3
  • A 10 mm lymph node lies at the conventional size threshold for suspicion (>10 mm); in the setting of active severe urinary infection, a reactive (inflammatory) node is highly plausible. [Journal of the American College of Radiology 2024] 3

Clinical Criteria for Urgent Decompression (Obstructive Pyelonephritis)

  • Fever ≥ 38.3 °C with flank pain
  • Leukocytosis > 14 000 /mm³ (likelihood ratio 3.7 for documented bacterial infection)
  • Sepsis signs (hypotension, tachycardia)
  • Imaging evidence of hydronephrosis or perirenal stranding

  • Combining urgent decompression with IV ceftriaxone 1–2 g improves survival from ≈ 60 % (antibiotics alone) to ≈ 92 %. [Praxis Medical Insights 2026] 1

Therapeutic Management

  • Replace the colonised JJ stent and obtain cultures from both the device and urine. [Ca‑A Cancer Journal for Clinicians 2023] 2
  • Targeted antibiotic therapy based on susceptibility (e.g., ceftriaxone or ampicillin‑sulbactam) reduces septic complications from ≈ 50 % to ≈ 9 %. [Ca‑A Cancer Journal for Clinicians 2023] 2
  • Continue therapy until full clinical and laboratory resolution (fever, pain, leukocytosis, and sterile urine culture). [Praxis Medical Insights 2026] [1][4]

Follow‑up and Surveillance

  • Re‑evaluate the lymph node after complete infection control; postpone repeat PET/CT for at least 4–6 weeks post‑resolution. [Praxis Medical Insights 2026] 4
  • Decreased or absent FDG uptake on the follow‑up scan supports a reactive inflammatory node. [Journal of the American College of Radiology 2024] 3
  • Persistent or increased node size/uptake after infection eradication suggests possible neoplastic recurrence and warrants further work‑up. [Ca‑A Cancer Journal for Clinicians 2023] 2
  • If diagnostic uncertainty remains, perform an image‑guided lymph‑node biopsy for definitive histology. [Journal of the American College of Radiology 2024] 3

Stent Management Recommendations

  • Systematic replacement of JJ stents is advised; duration of indwelling time is the chief infection risk factor. [Ca‑A Cancer Journal for Clinicians 2023] 2
  • Schedule routine exchanges every 3 months to minimise recurrent infections. [Ca‑A Cancer Journal for Clinicians 2023] 2
  • Reassess the indication for stent placement regularly and remove the device as soon as clinically feasible. [Ca‑A Cancer Journal for Clinicians 2023] 2

Resolution Criteria (Post‑Treatment)

  • Normalization of blood leukocyte count. [Praxis Medical Insights 2026] 4
  • Absence of fever and other clinical signs. [Praxis Medical Insights 2026] 1
  • Sterile urine culture while on therapy. [Praxis Medical Insights 2026] 4

REFERENCES

3

Management of Obstructive Pyelonephritis with Sepsis [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

4

Impact of Urinary Tract Infections on 24-Hour Urine Analysis in Patients with JJ Stents [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026